These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24733739)

  • 1. Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.
    Sarraf M; Perles-Barbacaru AT; Nissou MF; van der Sanden B; Berger F; Lahrech H
    Magn Reson Med; 2015 Mar; 73(3):1005-14. PubMed ID: 24733739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: Clinical translation of the Rapid-Steady-State-T1 MRI method for direct cerebral blood volume quantification.
    Perles-Barbacaru TA; Tropres I; Sarraf MG; Chechin D; Zaccaria A; Grand S; Le Bas JF; Berger F; Lahrech H
    Med Phys; 2015 Nov; 42(11):6369-75. PubMed ID: 26520728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.
    Perles-Barbacaru AT; van der Sanden BP; Farion R; Lahrech H
    J Cereb Blood Flow Metab; 2012 Mar; 32(3):489-501. PubMed ID: 22068227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative rapid steady state T1 magnetic resonance imaging for cerebral blood volume mapping in mice: Lengthened measurement time window with intraperitoneal Gd-DOTA injection.
    Perles-Barbacaru AT; Berger F; Lahrech H
    Magn Reson Med; 2013 May; 69(5):1451-6. PubMed ID: 22760854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation.
    Quarles CC; Ward BD; Schmainda KM
    Magn Reson Med; 2005 Jun; 53(6):1307-16. PubMed ID: 15906288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of vessel size index, relative blood volume, and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis.
    Kording F; Weidensteiner C; Zwick S; Osterberg N; Weyerbrock A; Staszewski O; von Elverfeldt D; Reichardt W
    J Magn Reson Imaging; 2014 Dec; 40(6):1310-8. PubMed ID: 24390982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
    Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
    Lemasson B; Serduc R; Maisin C; Bouchet A; Coquery N; Robert P; Le Duc G; Troprès I; Rémy C; Barbier EL
    Radiology; 2010 Nov; 257(2):342-52. PubMed ID: 20829544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.
    Valable S; Lemasson B; Farion R; Beaumont M; Segebarth C; Remy C; Barbier EL
    NMR Biomed; 2008 Nov; 21(10):1043-56. PubMed ID: 18615861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified spin and gradient echo approach for brain tumor perfusion imaging.
    Stokes AM; Quarles CC
    Magn Reson Med; 2016 Jan; 75(1):356-62. PubMed ID: 25753958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function.
    Kim JH; Im GH; Yang J; Choi D; Lee WJ; Lee JH
    NMR Biomed; 2012 Apr; 25(4):674-84. PubMed ID: 21954069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.
    Kim JH; Suh JY; Woo DC; Sung YS; Son WC; Choi YS; Pae SJ; Kim JK
    NMR Biomed; 2016 Dec; 29(12):1688-1699. PubMed ID: 27723161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
    Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
    Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster analysis of DCE-MRI data identifies regional tracer-kinetic changes after tumor treatment with high intensity focused ultrasound.
    Jacobs I; Hectors SJ; Schabel MC; Grüll H; Strijkers GJ; Nicolay K
    NMR Biomed; 2015 Nov; 28(11):1443-54. PubMed ID: 26390040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Weisskoff model valid for the correction of contrast agent extravasation with combined T1 and T2* effects in dynamic susceptibility contrast MRI?
    Liu HL; Wu YY; Yang WS; Chen CF; Lim KE; Hsu YY
    Med Phys; 2011 Feb; 38(2):802-9. PubMed ID: 21452717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard.
    Boxerman JL; Prah DE; Paulson ES; Machan JT; Bedekar D; Schmainda KM
    AJNR Am J Neuroradiol; 2012 Jun; 33(6):1081-7. PubMed ID: 22322605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
    White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
    J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.